-
1
-
-
79959355125
-
Human cytomegalovirus and kidney transplantation: A clinician's update
-
De Keyzer K, Van Laecke S, Peeters P, Vanholder R., Human cytomegalovirus and kidney transplantation: A clinician's update. Am J Kidney Dis 2011; 58: 118-126.
-
(2011)
Am J Kidney Dis
, vol.58
, pp. 118-126
-
-
De Keyzer, K.1
Van Laecke, S.2
Peeters, P.3
Vanholder, R.4
-
2
-
-
84877965931
-
CMV: Prevention, diagnosis and therapy
-
Kotton CN,. CMV: Prevention, diagnosis and therapy. Am J Transplant 2013; 13: 24-40.
-
(2013)
Am J Transplant
, vol.13
, pp. 24-40
-
-
Kotton, C.N.1
-
3
-
-
84883455574
-
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
-
Kotton CN, Kumar D, Caliendo AM, et al., Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013; 96: 333-360.
-
(2013)
Transplantation
, vol.96
, pp. 333-360
-
-
Kotton, C.N.1
Kumar, D.2
Caliendo, A.M.3
-
4
-
-
84903401627
-
Emerging cytomegalovirus management strategies after solid organ transplantation: Challenges and opportunities
-
Beam E, Dioverti V, Razonable RR., Emerging cytomegalovirus management strategies after solid organ transplantation: Challenges and opportunities. Curr Infect Dis Rep 2014; 16: 419.
-
(2014)
Curr Infect Dis Rep
, vol.16
, pp. 419
-
-
Beam, E.1
Dioverti, V.2
Razonable, R.R.3
-
5
-
-
77950926374
-
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation
-
Kotton CN, Kumar D, Caliendo AM, et al., International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89: 779-795.
-
(2010)
Transplantation
, vol.89
, pp. 779-795
-
-
Kotton, C.N.1
Kumar, D.2
Caliendo, A.M.3
-
6
-
-
82755189443
-
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients
-
de la Torre-Cisneros J, Fariñas MC, Castõn JJ, et al., GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin 2011; 29: 735-758.
-
(2011)
Enferm Infecc Microbiol Clin
, vol.29
, pp. 735-758
-
-
De La Torre-Cisneros, J.1
Fariñas, M.C.2
Castõn, J.J.3
-
7
-
-
84904696541
-
Delayed-onset cytomegalovirus disease coded during hospital readmission after kidney transplantation
-
Santos CAQ, Brennan DC, Fraser VJ, Olsen MA., Delayed-onset cytomegalovirus disease coded during hospital readmission after kidney transplantation. Transplantation 2014; 98: 187-194.
-
(2014)
Transplantation
, vol.98
, pp. 187-194
-
-
Santos, C.A.Q.1
Brennan, D.C.2
Fraser, V.J.3
Olsen, M.A.4
-
8
-
-
40749108069
-
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation
-
Arthurs SK, Eid AJ, Pedersen RA, et al., Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 2008; 46: 840-846.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 840-846
-
-
Arthurs, S.K.1
Eid, A.J.2
Pedersen, R.A.3
-
9
-
-
84925021519
-
Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment
-
Stern M, Hirsch H, Cusini A, et al., Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. Transplantation 2014; 98: 1013-1018.
-
(2014)
Transplantation
, vol.98
, pp. 1013-1018
-
-
Stern, M.1
Hirsch, H.2
Cusini, A.3
-
10
-
-
13144268553
-
Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report
-
Preiksaitis JK, Brennan DC, Fishman J, Allen U., Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005; 5: 218-227.
-
(2005)
Am J Transplant
, vol.5
, pp. 218-227
-
-
Preiksaitis, J.K.1
Brennan, D.C.2
Fishman, J.3
Allen, U.4
-
11
-
-
37549024633
-
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation
-
Reischig T, Jindra P, Hes O, Svecova M, Klaboch J, Treska V., Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am J Transplant 2008; 8: 69-77.
-
(2008)
Am J Transplant
, vol.8
, pp. 69-77
-
-
Reischig, T.1
Jindra, P.2
Hes, O.3
Svecova, M.4
Klaboch, J.5
Treska, V.6
-
12
-
-
84897082126
-
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients
-
Roman A, Manito N, Maria Campistol, J, et al., The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients. Transplant Rev 2014; 28: 84-91.
-
(2014)
Transplant Rev
, vol.28
, pp. 84-91
-
-
Roman, A.1
Manito, N.2
Campistol, M.J.3
-
13
-
-
33744473322
-
Target of rapamycin inhibitors (Sirolimus and Everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomized trials
-
Webster AC, Lee VWS, Chapman JR, Craig JC., Target of rapamycin inhibitors (Sirolimus and Everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomized trials. Transplantation 2006; 81: 1234-1248.
-
(2006)
Transplantation
, vol.81
, pp. 1234-1248
-
-
Webster, A.C.1
Lee, V.W.S.2
Chapman, J.R.3
Craig, J.C.4
-
14
-
-
84857194014
-
Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: Pooled analysis of three clinical trials
-
Brennan DC, Legendre C, Patel D, et al., Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: Pooled analysis of three clinical trials. Am J Transplant 2011; 11: 2453-2462.
-
(2011)
Am J Transplant
, vol.11
, pp. 2453-2462
-
-
Brennan, D.C.1
Legendre, C.2
Patel, D.3
-
15
-
-
84872085198
-
Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? A systematic review and meta-analysis
-
Andrassy J, Hoffmann VS, Rentsch M, et al., Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? A systematic review and meta-analysis. Transplantation 2012; 94: 1208-1217.
-
(2012)
Transplantation
, vol.94
, pp. 1208-1217
-
-
Andrassy, J.1
Hoffmann, V.S.2
Rentsch, M.3
-
16
-
-
84906246466
-
A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients
-
Lim WH, Eris J, Kanellis J, et al., A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients. Am J Transplant 2014; 14: 2106-2119.
-
(2014)
Am J Transplant
, vol.14
, pp. 2106-2119
-
-
Lim, W.H.1
Eris, J.2
Kanellis, J.3
-
17
-
-
84862290097
-
Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor- based immunosuppressive therapy in de novo renal transplant recipients
-
Nashan B, Gaston R, Emery V, et al., Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor- based immunosuppressive therapy in de novo renal transplant recipients. Transplantation 2012; 93: 1075-1085.
-
(2012)
Transplantation
, vol.93
, pp. 1075-1085
-
-
Nashan, B.1
Gaston, R.2
Emery, V.3
-
18
-
-
84859711356
-
Everolimus plus early tacrolimus minimization: A phase III, randomized, open label, multicentre trials in enal transplantation
-
Langer RM, Hené R, Vitko S, et al., Everolimus plus early tacrolimus minimization: A phase III, randomized, open label, multicentre trials in enal transplantation. Transplant Int 2012; 25: 592-602.
-
(2012)
Transplant Int
, vol.25
, pp. 592-602
-
-
Langer, R.M.1
Hené, R.2
Vitko, S.3
-
19
-
-
37349034394
-
Reduced exposure to calcineurin inhibitors in renal transplantation
-
Ekberg H, Tedesco-Silva H, Demirbas A, et al., Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562-2575.
-
(2007)
N Engl J Med
, vol.357
, pp. 2562-2575
-
-
Ekberg, H.1
Tedesco-Silva, H.2
Demirbas, A.3
-
20
-
-
75749119257
-
Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups
-
Sis B, Mengel M, Haas M, et al., Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
-
(2010)
Am J Transplant
, vol.10
, pp. 464-471
-
-
Sis, B.1
Mengel, M.2
Haas, M.3
-
21
-
-
65649142017
-
A new equation to estimate glomerular filtration rate (vol 150, pg 604, 2009)
-
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III., Feldman HI,. A new equation to estimate glomerular filtration rate (vol 150, pg 604, 2009). Ann Intern Med 2011; 155: 604-612.
-
(2011)
Ann Intern Med
, vol.155
, pp. 604-612
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
Zhang, Y.L.4
Castro, A.F.5
Feldman, H.I.6
-
22
-
-
72449147738
-
The multifunctional role of mTOR in innate immunity: Implications for transplant immunity
-
Saemann MD, Haidinger M, Hecking M, Horl WH, Weichhart T., The multifunctional role of mTOR in innate immunity: Implications for transplant immunity. Am J Transplant 2009; 9: 2655-2661.
-
(2009)
Am J Transplant
, vol.9
, pp. 2655-2661
-
-
Saemann, M.D.1
Haidinger, M.2
Hecking, M.3
Horl, W.H.4
Weichhart, T.5
-
23
-
-
79953814668
-
Rapamycin increases the yield and effector function of human gammadelta T cells stimulated in vitro
-
Li H, Pauza CD., Rapamycin increases the yield and effector function of human gammadelta T cells stimulated in vitro. Cancer Immunol Immunother 2011; 60: 361-370.
-
(2011)
Cancer Immunol Immunother
, vol.60
, pp. 361-370
-
-
Li, H.1
Pauza, C.D.2
-
24
-
-
79952844950
-
The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection
-
Clippinger AJ, Maguire TG, Alwine JC., The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection. J Virol 2011; 85: 3930-3939.
-
(2011)
J Virol
, vol.85
, pp. 3930-3939
-
-
Clippinger, A.J.1
Maguire, T.G.2
Alwine, J.C.3
-
25
-
-
67650074206
-
MTOR regulates memory CD8 T-cell differentiation
-
Araki K, Turner AP, Shaffer VO, et al., mTOR regulates memory CD8 T-cell differentiation. Nature 2009; 460: 108-112.
-
(2009)
Nature
, vol.460
, pp. 108-112
-
-
Araki, K.1
Turner, A.P.2
Shaffer, V.O.3
-
26
-
-
77956893188
-
Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses
-
Ferrer IR, Wagener ME, Robertson JM, et al., Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J Immunol 2010; 185: 2004-8.
-
(2010)
J Immunol
, vol.185
, pp. 2004-2008
-
-
Ferrer, I.R.1
Wagener, M.E.2
Robertson, J.M.3
-
28
-
-
84901912546
-
Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients
-
16
-
Lee YM, Kim YH, Han DJ, et al., Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients. Transplant Infect Dis 2014; 16: 397-402.
-
(2014)
Transplant Infect Dis
, pp. 397-402
-
-
Lee, Y.M.1
Kim, Y.H.2
Han, D.J.3
-
29
-
-
84873409207
-
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling
-
Egli A, Kumar D, Broscheit C, O'Shea D, Humar A., Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. Transplantation 2013; 95: 448-455.
-
(2013)
Transplantation
, vol.95
, pp. 448-455
-
-
Egli, A.1
Kumar, D.2
Broscheit, C.3
O'Shea, D.4
Humar, A.5
-
30
-
-
84876290338
-
Randomized trial of everolimus- facilitated calcineurin inhibitor minimization over 24 months in renal transplantation
-
Cibrik D, Silva HT Jr., Vathsala A, et al., Randomized trial of everolimus- facilitated calcineurin inhibitor minimization over 24 months in renal transplantation. Transplantation 2013; 95: 933-942.
-
(2013)
Transplantation
, vol.95
, pp. 933-942
-
-
Cibrik, D.1
Silva, H.T.2
Vathsala, A.3
-
31
-
-
77957583305
-
Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial (vol 23, pg 1084 JT 2010)
-
Dantal J, Berthoux F, Moal MC, et al., Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial (vol 23, pg 1084 JT 2010). Transplant Int 2012; 25: 1084-1093.
-
(2012)
Transplant Int
, vol.25
, pp. 1084-1093
-
-
Dantal, J.1
Berthoux, F.2
Moal, M.C.3
-
32
-
-
84941942529
-
Efficacy and safety of everolimus with low-dose tacrolimus in de Novo renal transplant recipients: 12-month randomized study
-
Qazi Y, Shaffer D, Kaplan B, et al., Efficacy and safety of everolimus with low-dose tacrolimus in de Novo renal transplant recipients: 12-month randomized study. Am J Transplant 2014; 14: 80.
-
(2014)
Am J Transplant
, vol.14
, pp. 80
-
-
Qazi, Y.1
Shaffer, D.2
Kaplan, B.3
-
33
-
-
84978264145
-
Influence of induction therapy on the efficacy of everolimus vs mycophenolate based regimen in de novo renal transplant recipients
-
Vincenti F, Qazi Y, Kaplan B, et al., Influence of induction therapy on the efficacy of everolimus vs mycophenolate based regimen in de novo renal transplant recipients. Am J Transplant 2014; 14: 539-540.
-
(2014)
Am J Transplant
, vol.14
, pp. 539-540
-
-
Vincenti, F.1
Qazi, Y.2
Kaplan, B.3
|